A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health
<b>Background/Objectives</b>: Takeda’s tetravalent dengue vaccine TAK-003 has been approved by the Brazilian regulatory agency ANVISA for dengue disease prevention in individuals aged 4 to 60 years. Dourados, in the state of Mato Grosso do Sul, became the world’s first city to implement...
Saved in:
| Main Authors: | Benedetta Ghezzi, Cristina Valencia, Roberto Dias de Oliveira, Daniel Tsuha, Waldno Lucena Júnior, Alberta Di Pasquale, Morgan Mc Namara, Juliana Senra, Denise Abud, Julio Croda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/2/121 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TAK-003: development of a tetravalent dengue vaccine
by: Xavier Sáez-Llorens, et al.
Published: (2025-12-01) -
Dengue Vaccine Development and Deployment into Routine Immunization
by: Annelies Wilder-Smith, et al.
Published: (2025-04-01) -
Unveiling the complexity of vaccine hesitancy: A narrative review focusing on dengue vaccination
by: Rachata Charoenwisedsil, et al.
Published: (2025-12-01) -
NILAI TOTAL TAK TERATUR TOTAL DARI GABUNGAN TERPISAH GRAF RODA DAN GRAF BUKU SEGITIGA
by: R. D. S. Rahangmetan, et al.
Published: (2015-12-01) -
Design and Synthesis of Fluorescence-Labeled TAK779 Analogs as Chemical Probes
by: Hiroyuki Konno, et al.
Published: (2025-06-01)